KEY FEATURES
| Full Name | Activin A Receptor Type I |
|---|---|
| Synonym | ACVR1A; ALK2; ACVRLK2; TSRI; FOP; SKR1; ACTRI; Activin receptor-like kinase 2; Serine/threonine-protein kinase receptor R1; TGF-B superfamily receptor type I |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human ACVR1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ACVR1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ACVR1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ACVR1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ACVR1. You can calculate the concentration of Human ACVR1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ACVR1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.49 | 1.58 | 4.71 | 0.47 | 1.73 | 4.73 |
| Standard deviation | 0.03 | 0.07 | 0.15 | 0.03 | 0.09 | 0.24 |
| CV(%) | 6.57 | 4.27 | 3.19 | 5.7 | 5.44 | 5.09 |
RECOVERY
The recovery of Human ACVR1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-107 | 98 |
| EDTA plasma (n=8) | 93-107 | 100 |
| Cell culture media (n=8) | 86-99 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ACVR1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with ACVR1 ELISA Kits
| SMAD1 ELISA Kit | publications with ACVR1 and SMAD1 |
| BMP7 ELISA Kit | publications with ACVR1 and BMP7 |
| BMP2 ELISA Kit | publications with ACVR1 and BMP2 |
| SMAD5 ELISA Kit | publications with ACVR1 and SMAD5 |
| ENG ELISA Kit | publications with ACVR1 and ENG |
| TGFBR1 ELISA Kit | publications with ACVR1 and TGFBR1 |
| INHBB ELISA Kit | publications with ACVR1 and INHBB |
| INHBA ELISA Kit | publications with ACVR1 and INHBA |
| IKBKB ELISA Kit | publications with ACVR1 and IKBKB |
| FANCL ELISA Kit | publications with ACVR1 and FANCL |
Pathways associated with ACVR1 ELISA Kit
| ALK1 Pathway | ALK1 Pathway |
| ALK1 Signaling Events Pathway | ALK1 Signaling Events Pathway |
| ALK2 Signaling Events Pathway | ALK2 Signaling Events Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| TGF-beta Signaling Pathway | TGF-beta Signaling Pathway |
Diseases associated with ACVR1 ELISA Kit
| Muscular Diseases | publications with ACVR1 and Muscular Diseases |
| Myositis Ossificans | publications with ACVR1 and Myositis Ossificans |
| Neoplasms | publications with ACVR1 and Neoplasms |
| Vascular Diseases | publications with ACVR1 and Vascular Diseases |
| Inflammation | publications with ACVR1 and Inflammation |
| Nervous System Diseases | publications with ACVR1 and Nervous System Diseases |
| Gastrointestinal Diseases | publications with ACVR1 and Gastrointestinal Diseases |
| Cell Transformation, Neoplastic | publications with ACVR1 and Cell Transformation, Neoplastic |
| Intestinal Diseases | publications with ACVR1 and Intestinal Diseases |
| Ovarian Neoplasms | publications with ACVR1 and Ovarian Neoplasms |
Organs/Tissues associated with ACVR1 ELISA Kit
| Bone | publications with ACVR1 and Bone |
| Muscle | publications with ACVR1 and Muscle |
| Connective Tissue | publications with ACVR1 and Connective Tissue |
| Vascular | publications with ACVR1 and Vascular |
| Embryonic Tissue | publications with ACVR1 and Embryonic Tissue |
| Blood | publications with ACVR1 and Blood |
| Heart | publications with ACVR1 and Heart |
| Ovary | publications with ACVR1 and Ovary |
| Bone Marrow | publications with ACVR1 and Bone Marrow |
| Brain | publications with ACVR1 and Brain |